Mounjaro (tirzepatide) represents a significant advancement in injectable therapy for adults managing type 2 diabetes, administered via subcutaneous injection once weekly. The medication utilizes a dual GIP and GLP-1 receptor agonist mechanism,…
Mounjaro (tirzepatide) represents a significant advancement in injectable therapy for adults managing type 2 diabetes, administered via subcutaneous injection once weekly. The medication utilizes a dual GIP and GLP-1 receptor agonist mechanism,…